Merdad Parsey, Chief Medical Officer at GILEAD SCIENCES, INC. (GILD), sold 2,000 shares at $72.96 ($146K) on 2024-04-01, disclosed to the SEC on 2024-04-02.
Scheduled sale ($146k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| GILD | SELL | 2024-10-02 | $168K | — | Filing → |
| GILD | SELL | 2024-09-13 | $1.8M | — | Filing → |
| GILD | SELL | 2024-07-01 | $137K | — | Filing → |